Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nal-IRI + 5-FU/LV in Advanced Head & Neck and Esophageal SCC
NCT03712397Phase 2Completed
- Sponsor
- National Health Research Institutes
- Start
- Dec 2018
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in head and neck squamous cell carcinoma (HNSCC), Esophageal Squamous Cell Carcinoma (ESCC), sponsored by National Health Research Institutes. Started Dec 2018; status: completed.
02
Drugs
irinotecan
03
Conditions
head and neck squamous cell carcinoma (HNSCC)Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03712397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03712397.